SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA

被引：0
|
作者：
Vogelberg, C. [1 ]
Szefler, S. J. [2 ,3 ]
Hamelmann, E. [4 ,5 ]
Boner, A. [6 ]
Moroni-Zentgraf, P. [7 ]
Engel, M. [7 ]
El Azzi, G. [7 ]
Finnigan, H. [8 ]
Vandewalker, M. [9 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[2] Childrens Hosp Colorado, Dept Paediat, Aurora, CO USA
[3] Univ Colorado Denver, Sch Med, Aurora, CO USA
[4] Evangel Krankenhaus Bielefeld, Bochum, Germany
[5] Ruhr Univ, Allergy Ctr, Bochum, Germany
[6] Univ Verona, Dept Paediat, Verona, Italy
[7] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[8] Boehringer Ingelheim Ltd, Biostat & Data Sci, Bracknell, Berks, England
[9] Ozarks Inc, Clin Res, Columbia, MO USA
来源：
THORAX | 2016年 / 71卷
关键词：
INHALED CORTICOSTEROIDS;
D O I：
10.1136/thoraxjnl-2016-209333.298
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P155
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 50 条
  • [41] Tiotropium add-on therapy has a safety profile comparable with that of placebo in children and adolescents with symptomatic asthma
    Vogelberg, Christian
    Hamelmann, Eckard
    Vrijlandt, Elianne J. L. E.
    Engel, Michael
    El Azzi, Georges
    Moroni-Zentgraf, Petra
    Eickmeier, Olaf
    Vandewalker, Mark
    PEDIATRICS, 2018, 142
  • [42] Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
    J. Mark FitzGerald
    Eckard Hamelmann
    Huib A. M. Kerstjens
    Roland Buhl
    npj Primary Care Respiratory Medicine, 30
  • [43] Tiotropium add-on therapy has a safety profile comparable with that of placebo in children and adolescents with symptomatic asthma
    Vogelberg, C.
    Hamelmann, E.
    Vrijlandt, E.
    Engel, M.
    El Azzi, G.
    Moroni-Zentgraf, P.
    Eickmeier, O.
    Vandewalker, M.
    ALLERGY, 2017, 72 : 414 - 415
  • [44] TIOTROPIUM RESPIMAT (R) ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH MODERATE OR SEVERE SYMPTOMATIC ASTHMA, INDEPENDENT OF TH2 STATUS
    Casale, T.
    Dahl, R.
    Virchow, J. C.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H. A. M.
    THORAX, 2015, 70 : A152 - A153
  • [45] Once-daily Tiotropium Respimat® Add-on Therapy Improves Lung Function and Control in Adolescents and Children with Moderate Symptomatic Asthma
    Vogelberg, Christian
    Hamelmann, Eckard
    Szefler, Stanley J.
    El Azzi, Georges
    Moroni-Zentgraf, Petra
    Engel, Michael
    Sigmund, Ralf
    Vandewalker, Mark L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB95 - AB95
  • [46] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D. M. G.
    Paggiaro, P.
    Bleecker, E.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2014, 69 : A189 - A189
  • [47] Once-Daily Tiotropium Respimat® Add-On Therapy Improves Fef25-75% In Children And Adolescent Patients With Persistent Symptomatic Asthma
    Goldstein, S.
    Szefler, S. J.
    Vogelberg, C.
    Bensch, G.
    Given, J.
    El Azzi, G.
    Moroni-Zentgraf, P.
    Engel, M.
    Sigmund, R.
    Hamelmann, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D.
    Bateman, E. D.
    Paggiaro, P.
    Bleecker, E. R.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2015, 70 : A151 - A151
  • [49] ECONOMIC EVALUATION OF TIOTROPIUM ADMINISTRATED THROUGH THE RESPIMAT INHALER AS ADD-ON THERAPY IN PATIENTS WITH UNCONTROLLED SEVERE ASTHMA IN POLAND
    Pawlik, M.
    Walczak, J.
    Pieniazek, I
    VALUE IN HEALTH, 2015, 18 (07) : A502 - A502
  • [50] Tiotropium Respimat® Add-On Therapy Is Effective In Children And Adolescents With Severe Symptomatic Asthma, Irrespective Of Immunoglobulin E Levels And Eosinophil Count
    Goldstein, S.
    Vogelberg, C.
    Hamelmann, E.
    Szefler, S. J.
    Mansfield, L.
    Voelker, B.
    El Azzi, G.
    Sigmund, R.
    Engel, M.
    Vandewalker, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345